• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 3 out of 23 pages
Exam (elaborations)

NSG 4100 EXAM 3 ACTUAL Gastrointestinal, Hepatic, Hematologic, and Immune Disorders — 100-Question Practice Exam with Answer Key & Rationales

Document preview thumbnail
Preview 3 out of 23 pages

NSG 4100 EXAM 3 ACTUAL Gastrointestinal, Hepatic, Hematologic, and Immune Disorders — 100-Question Practice Exam with Answer Key & Rationales

Content preview

NSG 4100 EXAM 3 ACTUAL
Gastrointestinal, Hepatic, Hematologic, and Immune Disorders —
100-Question Practice Exam with Answer Key & Rationales

Section A: Hepatic & Pancreatic Disorders
Question 1: A client with cirrhosis develops ascites. Which mechanism primarily contributes to
this finding?
● A. Increased serum albumin
● B. Portal hypertension and decreased serum albumin causing fluid shift into the
peritoneal cavity
● C. Decreased portal pressure
● D. Excess protein synthesis by the liver
Rationale: Cirrhosis causes portal hypertension and decreased albumin synthesis, reducing
oncotic pressure and promoting fluid shift into the peritoneal cavity, resulting in ascites.

Question 2: A client with cirrhosis and ascites is prescribed spironolactone. What is the primary
reason this diuretic is preferred?
● A. It causes significant potassium loss
● B. It spares potassium, reducing risk of hypokalemia common in liver disease
● C. It has no effect on fluid balance
● D. It is contraindicated in liver disease
Rationale: Spironolactone is potassium-sparing, which is beneficial in cirrhosis since these
clients are already prone to electrolyte imbalances and hyperaldosteronism.

Question 3: A client with cirrhosis develops confusion, asterixis, and a fruity breath odor.
Which condition does the nurse suspect?
● A. Hepatic encephalopathy
● B. Hypoglycemia
● C. Diabetic ketoacidosis
● D. Hepatorenal syndrome
Rationale: Hepatic encephalopathy results from the liver's inability to clear ammonia, leading to
neurotoxic effects such as confusion, asterixis, and altered mental status.

Question 4: A client with hepatic encephalopathy is prescribed lactulose. What is the expected
therapeutic effect?
● A. Increase ammonia absorption
● B. Trap ammonia in the gut and promote its excretion through the stool
● C. Increase serum protein levels
● D. Decrease bowel motility

,Rationale: Lactulose acidifies the colon, converting ammonia to a form that is trapped and
excreted in the stool, lowering serum ammonia levels.

Question 5: A nurse is evaluating the effectiveness of lactulose therapy in a client with hepatic
encephalopathy. Which finding indicates the medication is working?
● A. Fewer than 1 soft stool per day
● B. 2 to 3 soft stools per day with improved mental status
● C. Severe diarrhea with dehydration
● D. No change in bowel pattern
Rationale: The therapeutic goal of lactulose is typically 2-3 soft stools per day, which
corresponds with decreased ammonia levels and improved mental status.

Question 6: A client with esophageal varices develops sudden hematemesis. What is the nurse's
priority action?
● A. Position the client supine and assess vital signs, preparing for possible emergency
intervention
● B. Encourage the client to eat
● C. Administer an oral laxative
● D. Delay treatment until the next scheduled assessment
Rationale: Bleeding esophageal varices are a life-threatening emergency; the nurse should
assess airway, breathing, circulation, and vital signs while preparing for interventions such as
endoscopy or balloon tamponade.

Question 7: A client with esophageal varices is prescribed a nonselective beta blocker such as
propranolol. What is the purpose of this medication?
● A. Increase portal pressure
● B. Reduce portal hypertension and decrease risk of variceal bleeding
● C. Increase heart rate
● D. Treat infection
Rationale: Nonselective beta blockers reduce portal pressure by decreasing cardiac output and
splanchnic blood flow, lowering the risk of variceal hemorrhage.

Question 8: A client with cirrhosis has a prolonged prothrombin time. What is the underlying
cause?
● A. Excess vitamin K
● B. Decreased hepatic synthesis of clotting factors
● C. Increased platelet production
● D. Excess bile production
Rationale: The liver synthesizes most clotting factors; cirrhosis impairs this function, leading to
prolonged PT/INR and increased bleeding risk.

, Question 9: A client with acute pancreatitis reports severe epigastric pain radiating to the back.
Which laboratory finding supports this diagnosis?
● A. Elevated serum lipase and amylase
● B. Decreased white blood cell count
● C. Decreased blood glucose
● D. Elevated hemoglobin
Rationale: Elevated serum lipase and amylase are key diagnostic markers for acute pancreatitis,
reflecting pancreatic enzyme release and tissue injury.

Question 10: A nurse is caring for a client with acute pancreatitis. Which intervention is a
priority for pain and pancreatic rest?
● A. Encourage a high-fat diet immediately
● B. Maintain NPO status and manage pain as prescribed
● C. Encourage large frequent meals
● D. Restrict all IV fluids
Rationale: NPO status reduces pancreatic stimulation and allows the gland to rest, while pain
management is essential for comfort in acute pancreatitis.

Question 11: A client with acute pancreatitis develops hypocalcemia. What is the likely cause?
● A. Excess dietary calcium
● B. Calcium binding with fatty acids released during pancreatic tissue necrosis
(saponification)
● C. Increased parathyroid hormone
● D. Renal failure only
Rationale: In pancreatitis, fat necrosis releases fatty acids that bind calcium (saponification),
leading to hypocalcemia; the nurse should monitor for tetany and Chvostek's/Trousseau's signs.

Question 12: A client with chronic pancreatitis reports steatorrhea and weight loss. What is the
underlying cause?
● A. Excess pancreatic enzyme secretion
● B. Insufficient pancreatic enzymes leading to malabsorption of fats
● C. Excess bile production
● D. Increased gastric acid secretion
Rationale: Chronic pancreatitis damages exocrine pancreatic tissue, reducing enzyme secretion
needed for fat digestion, resulting in steatorrhea and malabsorption.

Question 13: A client with chronic pancreatitis is prescribed pancrelipase. When should this
medication be taken?
● A. On an empty stomach at bedtime
● B. With meals and snacks
● C. Once daily in the morning only

Document information

Uploaded on
August 3, 2026
Number of pages
23
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$18.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
JPaul
5.0
(1)
Sold
7
Followers
0
Items
964
Last sold
3 months ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions